Kuczkowska, Katarzyna
Bjerkan, Louise
Stubsrud, Elisabeth
Husbyn, Hannah Cuthbertson
Chellappa, Stalin
Hauge, Anette
Skarshaug, Renate
Torgersen, Maria Lyngaas
Heim, Joel Benjamin
Jørgensen, Marthe Jøntvedt
Wold, Christian Winther
Schleimann, Mariane Høgsbjerg
Tolstrup, Martin
Granum, Stine
Fredriksen, Agnete Brunsvik
Pedersen, Mikkel Wandahl
Norheim, Gunnstein
Funding for this research was provided by:
Norges Forskningsråd (321622)
Article History
Received: 2 January 2023
Accepted: 30 October 2023
First Online: 2 November 2023
Competing interests
: All authors affiliated with Nykode Therapeutics, Oslo, Norway are employees of Nykode Therapeutics ASA, a biopharmaceutical company dedicated to discovering and developing novel immunotherapies. All authors may hold shares or stock options in the company. ABF, ES, SG, JBH, and GN are inventors of one or more patents on DNA vaccines and their uses.